Anaphylaxis following the use of a plasma-derived immunopurified monoclate-P, and the recombinant Recombinate and Kogenate factor VIII: a therapeutic challenge.
Pernod
G
G
Armari
C
C
Barro
C
C
Plantaz
D
D
Caperan
D
D
Jacquot
C
C
Polack
B
B
D000707:Anaphylaxis / Q000139:chemically induced*; D005169:Factor VIII / Q000302:isolation & purification / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII